Navigation Links
Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis
Date:5/30/2012

RESEARCH TRIANGLE PARK, N.C., May 30, 2012 /PRNewswire/ -- Stiefel, a GSK (NYSE: GSK) company, and Welichem Biotech, Inc. (WBI:CN), have entered into an agreement for the acquisition by Stiefel of exclusive development and commercialization rights to the novel anti-inflammatory agent, WBI-1001, in all territories outside of China, Taiwan, Macao and Hong Kong.  WBI-1001 is currently in Phase II clinical development for the treatment of psoriasis and atopic dermatitis. The transaction is subject to approval by Welichem shareholders.

Welichem will receive an initial payment of CAD$35 million and is eligible to receive additional milestone payments upon achievement of certain clinical development milestones and upon commercialization in certain countries following marketing approval from the corresponding regulatory agencies.

Under terms of the agreement, Stiefel has also received a conditional right to acquire further exclusive rights to develop and commercialize WBI-1001 in China, Taiwan, Macao and Hong Kong, collectively.  Upon satisfaction of certain conditions, Welichem will receive an additional payment of CAD$15million. 

"I'm delighted to build upon Stiefel's clinical pipeline of novel dermatology assets with the acquisition of WBI-1001," said Barbara White, Senior Vice President and Head of Research and Development, Stiefel. "We have a strong commitment to patients with skin conditions and are excited to undertake development of this innovative agent."

About WBI-1001: WBI-1001 is a novel, non-steroidal, topical anti-inflammatory new chemical entity (NCE) that has demonstrated efficacy and safety in Ph1 and Ph2 clinical trials for the treatment of mild to moderate psoriasis[i] and moderate to severe atopic dermatitis[ii] for up to 12 weeks as a single therapy.

About Stiefel, a GSK company 
Stiefel, a
'/>"/>

SOURCE Stiefel, a GSK company
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. CryoLife to Participate in 3rd Annual Benchmark Company, LLC One-on-One Investor Conference
2. Global Fund Celebrates Efforts of Partners Chevron, The Coca-Cola Company, (RED) and PEPFAR at Capitol Hill Event
3. Amorcyte, a NeoStem Company, Enrolls First Patient in PreSERVE Phase 2 Trial for Acute Myocardial Infarction
4. Goodwin Biotechnology and OncoMax, a Maxwell Biotech Portfolio Company, Announce a "Bench-to-Clinic" Collaboration for an Important Advance in Oncology
5. Heska to Present at the Sidoti & Company, LLC Semi-Annual New York Micro-Cap Conference
6. Kymos, a Catalan Company, Signs a Collaboration Agreement With the Pharmaceutical Group Ipsen
7. IPC The Hospitalist Company, Inc. Announces Patrick G. Hays Resignation From Board of Directors
8. InspireMD to Participate in Benchmark Company, LLC 2011 One-On-One Investor Conference
9. Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited
10. Newtech, Inc., a Leading Chinese EMS Patient Monitoring Company, Partners With Masimo to Incorporate rainbow® SET Noninvasive Measurement Capabilities Into New Patient Monitors
11. LaVoie Group Wins Gold Mercury Award For Medical Device Company, Alphatec Spine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... N.J. , May 22, 2013 MEDIFIRST ... opportunity to update shareholders about some recent company developments. ... expand its avenues of communication with shareholders. Integrating social ... launched a Facebook page and will post updates on ... Twitter hashtag is #medifirstusa. Says CEO ...
(Date:5/22/2013)... Ranbaxy Laboratories Limited (hereafter, Ranbaxy), a ... Sankyo), announced on May 22 the actions that ... past conduct under prior management ... continues to support Ranbaxy in its efforts to ... which led to the investigations by the U.S. ...
(Date:5/22/2013)... and REHOVOT, Israel , May 22, ... ), a leading developer and provider of microRNA-based molecular ... , President and Chief Executive Officer of Rosetta Genomics, ... Healthcare Conference taking place from June 3-6, 2013 in ... on Tuesday, June 4 th at 2:00 p.m. ...
Breaking Medicine Technology:Medifirst Solutions, Inc. Announces Update To Shareholders 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3
(Date:5/23/2013)... GBI Research’s analysis indicates that the global critical care ... of players accounting for a major proportion of the overall ... between 2006 and 2012, possibly due to the lack of ... in the US. , GBI Research estimates that the ... 2012, having grown in size at a CAGR of 11% ...
(Date:5/22/2013)... 2013 MileageAds.com, an American based full ... companies in the Stocks and Bonds Sector to display ... advertise with MileageAds will have the opportunity to take ... Stocks and bonds companies who accept Mileageads.com’s invitation will ... a specific, targeted audience on the internet ...
(Date:5/22/2013)... Boston, Mass, May 23, 2013 Existing research shows that ... risk of brain injury, but researchers at Boston Children,s ... place showed a 20 percent decrease in deaths and ... in bicycle-motor vehicle collisions. , The cross-sectional study, ... Lee, MD, MPH, Rebekah C. Mannix, MD, MPH of ...
(Date:5/22/2013)... The Yoga of Lady Niguma was created by a ... This is the oldest yoga found in written form (in ... the partner of renowned Indian master and yogi Naropa, and the ... a female yoga master. , Lady Niguma taught the practice ... through a long lineage to the second Dalai Lama, Gendun Gyatso. ...
(Date:5/22/2013)... May 22, 2013 A new study published ... found that of young people who visited fast food or ... who were obese were more likely to use calorie information ... also found that young people eating at fast food or ... likely to use calorie information as those eating there once ...
Breaking Medicine News(10 mins):Health News:MarketResearch.com Report – Increased Cost of Albumin was Main Factor for Double-Digit Growth of Global Critical Care Market Between 2006 and 2012 2Health News:Mileageads.com Ad Network Now Invites Companies in Stocks and Bonds Services Sector to Advertise on Their Ad Network 2Health News:Rate of bicycle-related fatalities significantly lower in states with helmet laws 2Health News:Popular Yoga DVD, Lady Niguma Yoga Released for Sale Online 2Health News:Popular Yoga DVD, Lady Niguma Yoga Released for Sale Online 3Health News:STRICTLY EMBARGOED UNTIL 6:00AM EST THURSDAY May 23, 2013; Calorie Information in Fast Food Restaurants Used by 40% of 9-18 Year Olds when Making Food Choices, Study Finds 2Health News:STRICTLY EMBARGOED UNTIL 6:00AM EST THURSDAY May 23, 2013; Calorie Information in Fast Food Restaurants Used by 40% of 9-18 Year Olds when Making Food Choices, Study Finds 3
... HealthDay Reporter , WEDNESDAY, March 16 (HealthDay News) ... to show a benefit for women with a rare lung ... a treatment. The drug, sirolimus (Rapamycin), improved both lung ... or LAM, according to a study published online March 16 ...
... -- On March 28, leading experts across multiple disciplines ... Therapies for Type 2 Diabetes to review the latest ... three-day meeting, hosted by NewYork-Presbyterian Hospital/Weill Cornell Medical Center ... and policymakers representing 60 countries. The Congress director is ...
... Carolina State University shows that while the number of visits ... for park operations has been significantly reduced. The reduction in ... than $20 billion in economic impact that state parks have ... support for operations puts stress on America,s state-park systems," says ...
... follow-up care for depression effectively and efficiently, according to ... that the Journal of General Internal Medicine ... months, compared to the half of the patients randomly ... three online care management contacts with a trained psychiatric ...
... loss and sleep disorders to health problems such as ... latest findings in sleep research will be presented and ... when the SLEEP 2011 25th Anniversary Meeting of the ... Convention Center from June 13 to 15. ...
... -- Newly proposed national standards for mercury, arsenic and ... as many as 17,000 premature deaths and 11,000 heart ... Agency. The proposed standards, released Wednesday by the ... prevent 120,000 cases of childhood asthma symptoms and 11,000 ...
Cached Medicine News:Health News:Transplant Drug May Fight Rare Lung Disorder 2Health News:Transplant Drug May Fight Rare Lung Disorder 3Health News:Diabetes Surgery 2nd World Congress 2Health News:Diabetes Surgery 2nd World Congress 3Health News:Diabetes Surgery 2nd World Congress 4Health News:Diabetes Surgery 2nd World Congress 5Health News:Study shows attendance at state parks grows, even as funding decreases 2Health News:Online messaging delivers follow-up care for depression 2Health News:EPA Proposes Tougher Air Pollution Rules for Power Plants 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: